Spyre Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Spyre Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2016 to Q4 2023.
  • Spyre Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $0.000.
Unrecognized Tax Benefits, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 $0 Dec 31, 2023 10-K/A 2024-11-18
Q4 2022 $0 $0 Dec 31, 2022 10-K/A 2024-11-18
Q4 2021 $0 $0 Dec 31, 2021 10-K 2023-03-02
Q4 2020 $0 $0 Dec 31, 2020 10-K 2022-03-08
Q4 2019 $0 $0 Dec 31, 2019 10-K 2021-03-18
Q4 2018 $0 $0 Dec 31, 2018 10-K 2021-03-18
Q4 2017 $0 $0 Dec 31, 2017 10-K 2019-03-07
Q4 2016 $0 Dec 31, 2016 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.